Literature DB >> 25940384

Dissecting genetic and environmental mutation signatures with model organisms.

Romulo Segovia1, Annie S Tam1, Peter C Stirling1.   

Abstract

Deep sequencing has impacted on cancer research by enabling routine sequencing of genomes and exomes to identify genetic changes associated with carcinogenesis. Researchers can now use the frequency, type, and context of all mutations in tumor genomes to extract mutation signatures that reflect the driving mutational processes. Identifying mutation signatures, however, may not immediately suggest a mechanism. Consequently, several recent studies have employed deep sequencing of model organisms exposed to discrete genetic or environmental perturbations. These studies exploit the simpler genomes and availability of powerful genetic tools in model organisms to analyze mutation signatures under controlled conditions, forging mechanistic links between mutational processes and signatures. We discuss the power of this approach and suggest that many such studies may be on the horizon.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cancer genomics; deep sequencing; model organisms; mutagens; mutation signature

Mesh:

Year:  2015        PMID: 25940384     DOI: 10.1016/j.tig.2015.04.001

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  7 in total

1.  Hypermutation signature reveals a slippage and realignment model of translesion synthesis by Rev3 polymerase in cisplatin-treated yeast.

Authors:  Romulo Segovia; Yaoqing Shen; Scott A Lujan; Steven J M Jones; Peter C Stirling
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-21       Impact factor: 11.205

2.  Attribution of Cancer Origins to Endogenous, Exogenous, and Preventable Mutational Processes.

Authors:  Vincent L Cannataro; Jeffrey D Mandell; Jeffrey P Townsend
Journal:  Mol Biol Evol       Date:  2022-05-03       Impact factor: 8.800

Review 3.  Base changes in tumour DNA have the power to reveal the causes and evolution of cancer.

Authors:  M Hollstein; L B Alexandrov; C P Wild; M Ardin; J Zavadil
Journal:  Oncogene       Date:  2016-06-06       Impact factor: 9.867

4.  Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and Nigeria.

Authors:  Shengfeng Wang; Jason J Pitt; Yonglan Zheng; Toshio F Yoshimatsu; Guimin Gao; Ayodele Sanni; Olayiwola Oluwasola; Mustapha Ajani; Dominic Fitzgerald; Abayomi Odetunde; Galina Khramtsova; Ian Hurley; Abiodun Popoola; Adeyinka Falusi; Temidayo Ogundiran; John Obafunwa; Oladosu Ojengbede; Nasiru Ibrahim; Jordi Barretina; Kevin P White; Dezheng Huo; Olufunmilayo I Olopade
Journal:  Int J Cancer       Date:  2019-06-27       Impact factor: 7.396

5.  Low-abundance mutations in colorectal cancer patients and healthy adults.

Authors:  Yanfei Li; Zhengsheng Dai; Gang Huang; Yueling Jin; Zhongping Ning; Junwei Shen
Journal:  Aging (Albany NY)       Date:  2020-01-12       Impact factor: 5.682

6.  MutSpec: a Galaxy toolbox for streamlined analyses of somatic mutation spectra in human and mouse cancer genomes.

Authors:  Maude Ardin; Vincent Cahais; Xavier Castells; Liacine Bouaoun; Graham Byrnes; Zdenko Herceg; Jiri Zavadil; Magali Olivier
Journal:  BMC Bioinformatics       Date:  2016-04-18       Impact factor: 3.169

7.  Characteristics of mutational signatures of unknown etiology.

Authors:  Xiaoju Hu; Zhuxuan Xu; Subhajyoti De
Journal:  NAR Cancer       Date:  2020-09-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.